| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/10/2001 | EP1066285A1 Antagonists of gonadotropin releasing hormone |
| 01/10/2001 | EP1066284A1 Benzo c]quinolizine derivatives and their use as 5 alpha-reductases inhibitors |
| 01/10/2001 | EP1066283A2 Substituted indolealkanoic acids |
| 01/10/2001 | EP1066280A1 Halimide, a cytotoxic marine natural product, and derivatives thereof |
| 01/10/2001 | EP1066279A1 Imidazolone anorectic agents: ii. phenyl derivatives |
| 01/10/2001 | EP1066278A1 Imidazolone anorectic agents: iii. heteroaryl derivatives |
| 01/10/2001 | EP1066277A1 Polyethoxylated ascorbic acid derivatives as a novel antioxidant and process for preparing thereof |
| 01/10/2001 | EP1066273A1 Metalloproteinase inhibitors |
| 01/10/2001 | EP1066272A1 Novel compounds useful in the complement, coagulat and kallikrein pathways and method for their preparation |
| 01/10/2001 | EP1066271A1 Thiocarboxamide derivatives and their use as inhibitors of alpha-4 integrins |
| 01/10/2001 | EP1066269A1 Trisubstituted 1,3,5-triazine derivatives for treatment of hiv infections |
| 01/10/2001 | EP1066268A1 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists |
| 01/10/2001 | EP1066266A1 Cyclin dependent kinase inhibitors |
| 01/10/2001 | EP1066265A1 Pyridazinone hydrochloride compound and method for producing the same |
| 01/10/2001 | EP1066262A1 Imidazolone anorectic agents: i. acyclic derivatives |
| 01/10/2001 | EP1066261A1 Pyridine derivative and pharmaceutical containing the same |
| 01/10/2001 | EP1066257A2 Heterocylic classes of compounds for the modulating tyrosine protein kinase |
| 01/10/2001 | EP1066254A1 C11 oxymyl and hydroxylamino prostaglandins useful as fp agonists |
| 01/10/2001 | EP1066247A1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 01/10/2001 | EP1066245A1 Novel local anesthetic compounds and uses |
| 01/10/2001 | EP1066221A2 Vectors and viruses used in gene therapy |
| 01/10/2001 | EP1066057A1 Hemoglobin-polysaccharide conjugates |
| 01/10/2001 | EP1066047A1 Methods and materials for treating inflammatory diseases |
| 01/10/2001 | EP1066044A1 Dextran formulations and method for treatment of inflammatory joint disorders |
| 01/10/2001 | EP1066043A2 Materials and methods relating to the treatment of conditions involving mast cells, basophils and eosinophils |
| 01/10/2001 | EP1066042A2 Steroidal saponins for treating alzheimer's disease |
| 01/10/2001 | EP1066041A1 THE USE OF ESTRADIOL DERIVATIVES FOR TREATING SIDE-EFFECTS DURING AND/OR AFTER GnRHa THERAPY |
| 01/10/2001 | EP1066040A1 Pharmaceutical composition containing cefuroxime axetil stable for moisture absorption |
| 01/10/2001 | EP1066039A1 Substituted quinazolines and analogs and the use thereof |
| 01/10/2001 | EP1066038A2 Use of cabergoline in the treatment of restless legs syndrome |
| 01/10/2001 | EP1066036A1 Agents with serotonin-related activity for the treatment for sleep apnea |
| 01/10/2001 | EP1066035A2 Substituted aromatic compounds for treatment of antibiotic resistant infections |
| 01/10/2001 | EP1066034A1 Oxy-vanadium (iv) complexes having spermicidal activity |
| 01/10/2001 | EP1066033A1 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease |
| 01/10/2001 | EP1066030A1 Topical hormonal composition with systemic effect |
| 01/10/2001 | EP1066029A1 Peroral active agent suspension |
| 01/10/2001 | EP1066027A1 Pharmaceutical composition of topiramate |
| 01/10/2001 | EP1066025A1 Polyalkoxy copolymers as lipase inhibitors and their compositions |
| 01/10/2001 | EP1066017A1 Use of retinoic acid activity inhibitors to slow down hair loss |
| 01/10/2001 | EP1066016A1 Poly-aminoacid derivatives and their use in compositions for treating keratinous fibres |
| 01/10/2001 | EP1065945A1 Method for producing a fat mixture |
| 01/10/2001 | EP1065931A1 Compositions containing a combination of a creatine compound and a second agent |
| 01/10/2001 | EP1056722A4 Bisulfate salt of hiv protease inhibitor |
| 01/10/2001 | EP0944310A4 Stabilized ascorbyl compositions |
| 01/10/2001 | EP0896525A4 Methods of dry powder inhalation |
| 01/10/2001 | EP0888379B1 Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof |
| 01/10/2001 | EP0888116B1 Use of dehydroepiandrosterone for the treatment of addictions |
| 01/10/2001 | EP0862439A4 Ligands to enhance cellular uptake of biomolecules |
| 01/10/2001 | EP0796103B1 Use of incense in the treatment of alzheimer's disease |
| 01/10/2001 | EP0783501B1 pyrimidone derivatives with antifungal activity |
| 01/10/2001 | EP0649306B1 Ester derivatives of 4-aza-steroids |
| 01/10/2001 | CN1279687A Bi-and tri-cyclic nucleoside, nucleotide and oligonucleotide analoguse |
| 01/10/2001 | CN1279686A Inhibitors of nucleoside metabolism |
| 01/10/2001 | CN1279683A Method for producing f-methoxy-quinoline carboxylic acids |
| 01/10/2001 | CN1279682A bicyclic kinase inhibitors |
| 01/10/2001 | CN1279681A Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist |
| 01/10/2001 | CN1279680A Imidazole derivatives with inhabiting activity to transterasa and preparing method thereof |
| 01/10/2001 | CN1279677A Intermediates and methods useful in the semisynthesis of paclitaxel and analogs |
| 01/10/2001 | CN1279676A Pseudopolymorphic forms of z-[2-[4-(bis(4-fluorophenyl)methyl]-1-piperazinyl]ethozy] acetic and dihydrochloride |
| 01/10/2001 | CN1279674A 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analoguse), their preparation and their use in the treatment of neurological disorders |
| 01/10/2001 | CN1279673A ((Cyclo) alkyl substituted-.gamma.-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders |
| 01/10/2001 | CN1279672A Pyridazine derivatives and drugs containing the same as the active ingredient |
| 01/10/2001 | CN1279670A Substituted oximes as neurokinin antagonists |
| 01/10/2001 | CN1279669A Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 01/10/2001 | CN1279667A 4(3)-substituted-4(3)-aminonethyl-(thioxo)pyran(thiapyran)or-piperidine derivatives(=gabapendin analogues), their preparation and their use in treatment of neurological disorders |
| 01/10/2001 | CN1279666A NPY antagonists |
| 01/10/2001 | CN1279617A Combination of an aldose reductase inhibitor and a glycogen phosphorglase inhibitor |
| 01/10/2001 | CN1279615A Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders |
| 01/10/2001 | CN1279613A Use of sulfated oligosaccharides in lowering blood triglyceride levels |
| 01/10/2001 | CN1279612A Modulation of immune responses |
| 01/10/2001 | CN1279611A Mechod for treating postmenopausal women using ultra-low-doses of estrogen |
| 01/10/2001 | CN1279610A Method for inhibiting development of liver cancer and increasing survival in chronic hepadnavirus infection |
| 01/10/2001 | CN1279609A Combination of selective 5-HT antagonist and selective h5-HT antagonist or partial agonist |
| 01/10/2001 | CN1279608A Formulations comprising dissolved paroxetine |
| 01/10/2001 | CN1279607A Anaesthetic formulation |
| 01/10/2001 | CN1279606A Use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
| 01/10/2001 | CN1279605A Inihibition of lipoprotein oxidation |
| 01/10/2001 | CN1279604A Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration. |
| 01/10/2001 | CN1279582A Serotonin containing formulation or oral administration and method of use |
| 01/10/2001 | CN1279243A Cancer suppressing action of antisense nucleic acid to leukemia gene of bursa-dependent lymphocyte |
| 01/10/2001 | CN1279241A Tetracydic fluoquinolone carboxylic acid, its preparing process and medicinal composition containing it as active component |
| 01/10/2001 | CN1279240A Tetracyclic fluoquinolone carboxylic acid, its preparing process and medicinal composition containing it as active component |
| 01/10/2001 | CN1279239A Acridine carboxylic ester compound, preparation and medicinal composition thereof |
| 01/10/2001 | CN1279112A Composition with carbohydrate matrix containing liposoluble substance |
| 01/10/2001 | CN1279078A Medicine for treating psoriasis and its preparing process |
| 01/10/2001 | CN1279067A Defervescent picking for baby |
| 01/10/2001 | CN1279066A Shuangmidamo suppository and its preparing process |
| 01/10/2001 | CN1279065A Medicinal composition for treating dysmnesia and senile dementia |
| 01/10/2001 | CN1279064A Roptazol suppository and its preparing process |
| 01/10/2001 | CN1279036A Method and composition for extending sevice life of intestinal canal |
| 01/10/2001 | CN1060483C Intermediate of doramectin for antiparastic chemical and its preparing method |
| 01/10/2001 | CN1060482C Novel polyhydro derivatives of tylosine and process for their preparation |
| 01/10/2001 | CN1060479C Preparation method for inidazole derivatives |
| 01/10/2001 | CN1060473C Microbicidal triazolyl derivative |
| 01/10/2001 | CN1060472C Hydroxamic acid derivatives with tricylic substitution, their preparing methods, medicines containing them and uses thereof |
| 01/10/2001 | CN1060465C Antianaphylaxis, anti-asthma and anti-inflammatory new medicine |
| 01/10/2001 | CN1060384C Oral liquid against senility and preparation thereof |
| 01/10/2001 | CN1060370C Medical ointment for treating arthritis and hyperosteogeny |
| 01/10/2001 | CN1060353C Medicine for cough and asthma |
| 01/10/2001 | CN1060338C Antitussive liquid and preparation method |